News about Industrial talks

Addex Therapeutics Reports Promising Preclinical Results for Novel Chronic Cough Therapy

Addex Therapeutics’ experimental GABAB modulator shows potential as a well-tolerated, long-term treatment option for chronic cough, addressing a significant unmet need in idiopathic pulmonary fibrosis patients.

Industrial talks | 04/05/2026 | By News Bureau |  110

European Medicines Agency Launches Advisory Group to Tackle Vaccine Hesitancy

‘European Medicines’ Advisory Group aims to rebuild public trust, strengthen vaccine communication and counter misinformation across Europe.

Industrial talks | 02/05/2026 | By News Bureau |  126

Syngene Strengthens Leadership Team with Two Key Appointments

Maninder Kapoor Puri joins Syngene as Chief Human Resources Officer (CHRO) and Abhijit Zutshi as Chief Commercial Officer (CCO)

Industrial talks | 01/05/2026 | By News Bureau |  168

US FDA Recommends AstraZeneca's TRUQAP for PTEN-Deficient Prostate Cancer

US Food and Drug Administration (FDA) advisory panel backs TRUQAP (capivasertib) with abiraterone and ADT for PTEN-deficient metastatic hormone-sensitive prostate cancer, based on positive phase 3 CAPItello-281 results showing favorable benefit-risk.

Industrial talks | 01/05/2026 | By News Bureau

TESARO Provides Update on AnaptysBio Litigation

TESARO Inc., part of GlaxoSmithKline plc, provides an update on litigation with AnaptysBio Inc., reaffirming its declaratory judgment claim and intent to pursue the case at trial.

Industrial talks | 28/04/2026 | By News Bureau

IIT Kanpur Appoints Prof. Anil K. Lalwani as First Dean of Gangwal School of Medical Sciences & Technology

Indian Institute of Technology Kanpur appoints Prof. Anil K. Lalwani as Inaugural Dean of Gangwal School of Medical Sciences & Technology, strengthening innovation in digital health, medical robotics, and affordable healthcare solutions.

Industrial talks | 22/04/2026 | By News Bureau |  206

UK Accelerates Clinical Trials, Slashing Set-Up Time to Boost Patient Access

Government-backed reforms and Euro 137 million investment cut trial start times significantly, enabling faster access to innovative treatments through the National Health Service.

Industrial talks | 17/04/2026 | By News Bureau |  130

Adimab Collaborator GSK Receives Additional Marketing Approval for Depemokimab

Adimab Collaborator GSK has received additional marketing approval for depemokimab, marking the sixth collaborator program to reach the market and strengthening its biologics portfolio.

Industrial talks | 17/04/2026 | By News Bureau |  153

NIPER Mohali Partners with Novartis to Support Faculty Research

NIPER Mohali signs grant agreement with Novartis Healthcare to support faculty research through development pioneer grant, strengthen industry-academia synergy, and boost innovation and R&D capabilities.

Industrial talks | 16/04/2026 | By News Bureau |  144

US Food and Drug Administration Urges Compliance on Clinical Trial Reporting to Address Data Gaps

The US Food and Drug Administration has issued reminders to over 2,200 companies and researchers to submit clinical trial results, aiming to reduce reporting gaps and improve transparency in drug development.

Industrial talks | 15/04/2026 | By News Bureau |  211